bioRxiv · 10.1101/284570
Novel susceptibility loci and genetic regulation mechanisms for type 2 diabetes
Abstract
We conducted a meta-analysis of genome-wide association studies (GWAS) with [~]16 million genotyped/imputed genetic variants in 62,892 type 2 diabetes (T2D) cases and 596,424 controls of European ancestry. We identified 139 common and 4 rare (minor allele frequency < 0.01) variants associated with T2D, 42 of which (39 common and 3 rare variants) were independent of the known variants. Integration of the gene expression data from blood (n = 14,115 and 2,765) and other T2D-relevant tissues (n = up to 385) with the GWAS results identified 33 putative functional genes for T2D, three of which were targeted by approved drugs. A further integration of DNA methylation (n = 1,980) and epigenomic annotations data highlighted three putative T2D genes (CAMK1D, TP53INP1 and ATP5G1) with plausible regulatory mechanisms whereby a genetic variant exerts an effect on T2D through epigenetic regulation of gene expression. We further found evidence that the T2D-associated loci have been under purifying selection.
Source connections
Explore related subjects
Keep this discovery
Xue, A., Wu, Y., Zhu, Z., Zhang, F., Kemper, K. E., Zheng, Z., Yengo, L., Lloyd-Jones, L. R., Sidorenko, J., eQTLGen Consortium,, McRae, A. F., Visscher, P. M., Zeng, J., Yang, J.. 2018-03-20. Novel susceptibility loci and genetic regulation mechanisms for type 2 diabetes. https://doi.org/10.1101/284570
Cite the original work for its findings. Save a collection to share your selection of sources.